Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma

Clinical trial NCT05290194 · RECRUITING

Trial details

NCT number: NCT05290194
Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Radiotherapy PD-1 Inhibitor Capecitabine Nasopharyngeal Carcinoma

Start date: 2022-03-28
Primary completion: 2026-12-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.